| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| SMO业务(元) | 371,239,093.23 | - | 390,100,929.69 | 803,728,904.44 | 394,357,641.95 |
| CRO(元) | - | 176,968,380.02 | - | - | - |
| 药企(元) | - | 615,181,236.95 | - | - | - |
| 医院(元) | - | 21,297,442.26 | - | - | - |
| 器械及其他(元) | - | 29,057,338.59 | - | - | - |
| CRO业务(元) | 1,129,612.24 | - | - | - | - |
| 营业成本(元) | |||||
| SMO业务(元) | 333,459,863.23 | - | 298,064,673.55 | 607,745,501.42 | 290,261,170.43 |
| CRO(元) | - | 129,925,202.51 | - | - | - |
| 药企(元) | - | 468,141,465.54 | - | - | - |
| 医院(元) | - | 2,025,306.62 | - | - | - |
| 器械及其他(元) | - | 24,464,608.70 | - | - | - |
| CRO业务(元) | 721,550.30 | - | - | - | - |
| 毛利(元) | |||||
| SMO业务(元) | 37,779,230.00 | - | 92,036,256.14 | 195,983,403.02 | 104,096,471.52 |
| CRO(元) | - | 47,043,177.51 | - | - | - |
| 药企(元) | - | 147,039,771.41 | - | - | - |
| 医院(元) | - | 19,272,135.64 | - | - | - |
| 器械及其他(元) | - | 4,592,729.89 | - | - | - |
| CRO业务(元) | 408,061.94 | - | - | - | - |
| 毛利率(%) | |||||
| SMO业务(%) | 10.18 | - | 23.59 | 24.38 | 26.40 |
| CRO(%) | - | 26.58 | - | - | - |
| 药企(%) | - | 23.90 | - | - | - |
| 医院(%) | - | 90.49 | - | - | - |
| 器械及其他(%) | - | 15.81 | - | - | - |
| CRO业务(%) | 36.12 | - | - | - | - |
| 收入构成(%) | |||||
| SMO业务(%) | 99.70 | - | 100.00 | 100.00 | 100.00 |
| CRO(%) | - | 21.01 | - | - | - |
| 药企(%) | - | 73.02 | - | - | - |
| 医院(%) | - | 2.53 | - | - | - |
| 器械及其他(%) | - | 3.45 | - | - | - |
| CRO业务(%) | 0.30 | - | - | - | - |
| 毛利构成(%) | |||||
| SMO业务(%) | 98.93 | - | 100.00 | 100.00 | 100.00 |
| CRO(%) | - | 21.58 | - | - | - |
| 药企(%) | - | 67.47 | - | - | - |
| 医院(%) | - | 8.84 | - | - | - |
| 器械及其他(%) | - | 2.11 | - | - | - |
| CRO业务(%) | 1.07 | - | - | - | - |